Equity Fundraising

When we advise companies on fundraising, it’s about enabling them to achieve their full potential.

We understand that optimising terms is critical, but also finding the right long-term partner for the next phase of growth. So we work with entrepreneurs to help articulate their equity story, target the best investors and negotiate the right deal.

Results recognise that you’re leading a fast-growth business that needs to keep performing well and delivering to the growth plan — and on a practical note, we take a lot of the process work away from you to ensure you have the headspace and time to focus on the business.

Equity Fundraising Deals

Jul 2021
has received investment from
Jan 2021
has invested in
Nov 2020
has received investment from
Sep 2020
has received investment from
Jan 2020
has received investment from
Nov 2019
has invested in
Oct 2019
has acquired
Sep 2019
has received investment from
Sep 2019
has received investment from
Mar 2019
has invested in

Results. Great people creating great outcomes, together.

Latest Insights

Reports
21st July 2021

Marketing Services: Global M&A and Public Company Performance H1 2021

We are pleased to share with you the H1 2021 Marketing Services Sector Review, where we analyse global M&A activity and public market performance in the marketing services sector. We continue to see very good levels of deal activity in the Marketing Services sector with H1 2021 deal volume up by 22% on H1 2020 […]

Reports
19th July 2021

The Global Technology Market Review – Q2 2021

As we predicted in Q1, deal activity has continued to increase in Q2 and the technology market remains very strong for M&A and public trading and optimism for future growth remains very healthy across all the technology sectors we track. M&A continues to be driven by strong levels of investment by private equity (directly and […]

Insights
17th May 2021

The next chapter: Changing market dynamics in commercialisation and medical communications

The last twelve months have been a time of extraordinary activity in the commercialisation sector – the COVID-19 pandemic saw medcomms groups play a crucial part in keeping pharma companies connected with patients and healthcare professionals, and dealmaking was frenetic on both sides of the Atlantic, for smaller agencies as well as for emerging ‘CCOs’. […]